Stanford University Study Shows Early Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients

27-11-2013 Business Wire HealthComments (0)

OncologyPharmaceutical

Fluxion announced the presentation of the first pilot study results from Stanford Univ. aimed at isolating circulating tumor cells (CTCs) from early stage non-small cell lung cancer (NSCLC) patients.

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top